2/26
08:52 am
neo
3 Reasons to Avoid NEO and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Avoid NEO and 1 Stock to Buy Instead [Yahoo! Finance]
2/25
07:17 am
neo
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types [Yahoo! Finance]
Low
Report
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types [Yahoo! Finance]
2/25
07:05 am
neo
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
Low
Report
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
2/24
07:18 am
neo
NeoGenomics (NASDAQ:NEO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
2/24
06:48 am
neo
NeoGenomics (NASDAQ:NEO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
NeoGenomics (NASDAQ:NEO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/22
11:50 pm
neo
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness [Yahoo! Finance]
2/18
04:10 pm
neo
Why NeoGenomics (NEO) Shares Are Falling Today [Yahoo! Finance]
Low
Report
Why NeoGenomics (NEO) Shares Are Falling Today [Yahoo! Finance]
2/18
01:10 pm
neo
NeoGenomics (NASDAQ:NEO) had its "hold" rating reaffirmed by analysts at Benchmark Co..
Low
Report
NeoGenomics (NASDAQ:NEO) had its "hold" rating reaffirmed by analysts at Benchmark Co..
2/18
01:10 pm
neo
NeoGenomics (NASDAQ:NEO) had its "hold" rating reaffirmed by analysts at UBS Group AG.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "hold" rating reaffirmed by analysts at UBS Group AG.
2/18
08:13 am
neo
NeoGenomics (NASDAQ:NEO) had its price target raised by analysts at Needham & Company LLC from $14.00 to $15.00. They now have a "buy" rating on the stock.
High
Report
NeoGenomics (NASDAQ:NEO) had its price target raised by analysts at Needham & Company LLC from $14.00 to $15.00. They now have a "buy" rating on the stock.
2/18
07:29 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
High
Report
NeoGenomics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/18
07:05 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences
High
Report
NeoGenomics to Participate in Upcoming Investor Conferences
2/17
04:21 pm
neo
NeoGenomics Inc (NEO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
High
Report
NeoGenomics Inc (NEO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
2/17
01:02 pm
neo
NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
NeoGenomics, Inc. (NEO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/17
10:53 am
neo
NeoGenomics Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
NeoGenomics Q4 Earnings Call Highlights [Yahoo! Finance]
2/17
10:32 am
neo
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
High
Report
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/17
09:31 am
neo
NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
High
Report
NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
2/17
07:51 am
neo
NeoGenomics's (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]
Medium
Report
NeoGenomics's (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]
2/17
07:33 am
neo
NeoGenomics: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
NeoGenomics: Q4 Earnings Snapshot [Yahoo! Finance]
2/17
07:05 am
neo
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
Low
Report
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
2/15
10:11 pm
neo
NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For [Yahoo! Finance]
2/12
07:05 am
neo
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
Low
Report
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
1/27
07:05 am
neo
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
Low
Report
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
1/25
05:23 am
neo
NeoGenomics: Distribution Moat In Community Oncology [Seeking Alpha]
Low
Report
NeoGenomics: Distribution Moat In Community Oncology [Seeking Alpha]
1/14
07:36 am
neo
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.